157 related articles for article (PubMed ID: 8712048)
1. [Stasis priapism secondary to PGE1: transformation into high-flow priapism].
Negrín Díaz A; Díaz Romero F; Fernández Ramos J; Gutiérrez Hernández P; Arteaga Serrano F; Bañares Baudet F
Actas Urol Esp; 1996 Mar; 20(3):289-91. PubMed ID: 8712048
[TBL] [Abstract][Full Text] [Related]
2. [Priapism after intracavernous injection of PgE1 in two cases of impotence following total cysto-prostatectomy].
Llopis J; Romero JA; Gutiérrez R; Alvarez R; Talbot R; Vendrell JR; Barranco MA; Carretero P
J Urol (Paris); 1995; 101(2):104-6. PubMed ID: 8522852
[TBL] [Abstract][Full Text] [Related]
3. [Methylene blue: an effective therapeutic alternative for priapism induced by intracavernous injection of vasoactive agents].
Martínez Portillo FJ; Fernández Arancibia MI; Bach S; Alken P; Jünemann KP
Arch Esp Urol; 2002 Apr; 55(3):303-8. PubMed ID: 12068762
[TBL] [Abstract][Full Text] [Related]
4. Intracavernous pharmacotherapy: comparison of Moxisylyte and prostaglandin E1.
Buvat J; Lemaire A; Herbaut-Buvat M
Int J Impot Res; 1996 Jun; 8(2):41-6. PubMed ID: 8858388
[TBL] [Abstract][Full Text] [Related]
5. [Management of priapism induced by PGE1].
Guzman Martínez-Valls PL; Tomas Ros M; Ferrero Doria R; Morga Egea JP; Navas Pastor J; Rico Galiano JL; Sempere Gutierrez A; Fontana Compiano LO
Arch Esp Urol; 1998 Jun; 51(5):457-60. PubMed ID: 9675941
[TBL] [Abstract][Full Text] [Related]
6. The incidence and management of priapism in Western Australia: a 16 year audit.
Earle CM; Stuckey BG; Ching HL; Wisniewski ZS
Int J Impot Res; 2003 Aug; 15(4):272-6. PubMed ID: 12934055
[TBL] [Abstract][Full Text] [Related]
7. Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapy.
McMahon CG
Int J Impot Res; 2003 Oct; 15(5):383-4. PubMed ID: 14562142
[No Abstract] [Full Text] [Related]
8. The long-term safety of alprostadil (prostaglandin-E1) in patients with erectile dysfunction. The European Alprostadil Study Group.
Br J Urol; 1998 Oct; 82(4):538-43. PubMed ID: 9806184
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E1 in erectile dysfunction. Efficiency and incidence of priapism.
Schramek P; Dorninger R; Waldhauser M; Konecny P; Porpaczy P
Br J Urol; 1990 Jan; 65(1):68-71. PubMed ID: 2310934
[TBL] [Abstract][Full Text] [Related]
10. Effects of priapism lasting 24 hours or longer caused by intracavernosal injection of vasoactive drugs.
Kulmala RV; Tamella TL
Int J Impot Res; 1995 Jun; 7(2):131-6. PubMed ID: 7496442
[TBL] [Abstract][Full Text] [Related]
11. [Priapism induced by vasoactive drugs].
Allona Almagro A
Arch Esp Urol; 1996 Apr; 49(3):277-80. PubMed ID: 8702349
[TBL] [Abstract][Full Text] [Related]
12. Oral midodrine for prostaglandin e1 induced priapism in spinal cord injured patients.
Soler JM; Previnaire JG; Mieusset R; Plante P
J Urol; 2009 Sep; 182(3):1096-100. PubMed ID: 19616810
[TBL] [Abstract][Full Text] [Related]
13. Continuous epidural blockade for treatment of drug-induced priapism.
Bravenec BJ; Lenkovsky F; Iyer C; Vornik V; Sum-Ping J; Makary L; Evans KJ; Joshi GP
J Clin Anesth; 2011 Feb; 23(1):83-4. PubMed ID: 21296258
[No Abstract] [Full Text] [Related]
14. Priapism after transurethral alprostadil.
Bettocchi C; Ashford L; Pryor JP; Ralph DJ
Br J Urol; 1998 Jun; 81(6):926. PubMed ID: 9666789
[No Abstract] [Full Text] [Related]
15. Intracorporeal phenylephrine in the treatment of priapism.
Muruve N; Hosking DH
J Urol; 1996 Jan; 155(1):141-3. PubMed ID: 7490814
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of prostaglandin E1 and its main metabolites after intracavernous injection and short-term infusion of prostaglandin E1 in patients with erectile dysfunction.
Cawello W; Schweer H; Dietrich B; Seyberth HW; Albrecht D; Fox A; Hohmuth H
J Urol; 1997 Oct; 158(4):1403-7. PubMed ID: 9302131
[TBL] [Abstract][Full Text] [Related]
17. The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience.
Porst H
J Urol; 1996 Mar; 155(3):802-15. PubMed ID: 8583582
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
[TBL] [Abstract][Full Text] [Related]
19. [Priapism of low flow].
Ruiz Cerda JL; Moreno Pardo B; Server Pastor G; Osca García JM; Vera Donoso C; Jiménez Cruz JF
Actas Urol Esp; 1991; 15(6):510-4. PubMed ID: 1792989
[TBL] [Abstract][Full Text] [Related]
20. [Iatrogenic priapism caused by intracavernous injection of vasoactive drugs in the treatment of impotence].
Bondil P
Presse Med; 1986 Apr; 15(14):665. PubMed ID: 2939440
[No Abstract] [Full Text] [Related]
[Next] [New Search]
